$BILL

Cieri Michael sold $130K of BILL

Cieri Michael (Chief Product Officer) sold 3,500 shares of BILL Holdings, Inc. (BILL) at $37.10 ($0.13M total) on 2026-05-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cieri Michael
Published Jun 1, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BILL
Neutral
medium confidence
Mentioned
$BILL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BILLNeutralLow
01

Why it matters

The disclosure confirms an officer open-market sale (3,500 shares at ~$37.10) executed under a pre-arranged 10b5-1 plan; this typically reduces interpretive weight versus discretionary selling.

02

Market read

Traders may note the insider sale as a sentiment datapoint, but it is unlikely to drive a fundamental repricing on its own.

03

What to watch

The article lacks context on total holdings history, whether sales cluster around option exercises/vesting, and whether other insiders filed around the same time.

Relevance 6/10Novelty 3/10Timing: Filed June 1, covering a sale on May 29

Background

The article is an SEC insider transaction disclosure (Form 4) for BILL Holdings, Inc.

Company-level read

Ticker impact

$BILLNeutralMedium confidence
Context

SEC Form 4 shows Chief Product Officer Michael Cieri sold about 3,500 shares of BILL under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless paired with other company-specific catalysts.

Evidence & confidence

The filing provides a concrete transaction datapoint (size, price, date) but not new fundamentals; 10b5-1 plans are typically used to reduce timing-based inference.

Market effects

Minimal—single-company insider transaction without accompanying operational/regulatory news.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or unusually large sales can still coincide with internal risk management or liquidity needs; monitor for follow-on filings.

Key entities

  • BILL Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Michael Cieri

    Chief Product Officer who sold shares under a 10b5-1 plan.

Related articles